LUNG 1.82 ▼ -1.09% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pulmonx Corporation

    NASDAQ: LUNG · Real-Time Price · USD
    1.82
    -0.02 (-1.09%)
    At close: Sep 23, 2025, 3:59 PM
    1.82
    0.00%
    After-hours: Sep 23, 2025, 04:14 PM EDT
    -1.09%
    Bid 1.39
    Market Cap 74.16M
    Revenue (ttm) 90.55M
    Net Income (ttm) -56.94M
    EPS (ttm) -1.43
    PE Ratio (ttm) -1.27
    Forward PE -1.38
    Analyst Buy
    Dividends n/a
    Ask 2.31
    Volume 442,864
    Avg. Volume (20D) 637,184
    Open 1.85
    Previous Close 1.84
    Day's Range 1.81 - 1.96
    52-Week Range 1.47 - 9.37
    Beta 0.43
    Ex-Dividend Date n/a

    About LUNG

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol LUNG
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for LUNG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Pulmonx Corporation is scheduled to release its earnings on Oct 29, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    -41.59%
    Pulmonx shares are trading lower after the company... Unlock content with Pro Subscription
    1 month ago
    +1.94%
    Pulmonx shares are trading lower after the company reported Q2 financial results and cut its FY25 sales guidance below estimates.
    news image

    4 weeks ago · zacks.com

    What Makes Pulmonx (LUNG) a New Buy Stock

    Pulmonx (LUNG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    news image

    1 month ago · zacks.com

    After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG)

    Pulmonx (LUNG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates c...

    news image

    1 month ago · seekingalpha.com

    Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript

    Pulmonx Corporation (NASDAQ:LUNG ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 AM ET Company Participants Mehul Joshi - Chief Financial Officer Steven S. Williamson - CEO, President & Director...

    news image

    1 month ago · zacks.com

    Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates

    Pulmonx Corporation (LUNG) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.39 per share a year ago.

    Add to Watchlist